Project

Medicine Safety Improvement Programme

Focus areas:
Locality:
Wessex
Compilation of images of people working in health and social care

The National Medicines Safety Improvement Programme (MedSIP) is part of The NHS Patient Safety Strategy The programme aims to address the most important causes of severe harm associated with medicines, that continue to challenge the health and care systems in England.

A new programme launched in April 2025 is focused on reducing harm from psychotropics used for behaviour that challenges in people with a learning disability. Behaviour that challenges is not a diagnosis, it describes a range of behaviours that some people with learning disability may display when their needs are not being met.


Compilation of images of people working in health and social care

Around 1.3 million people in England are living with a Learning Disability. People with Learning Disabilities experience some of the largest health inequalities in England. They are 14 times more likely to be prescribed antipsychotic medicines and twice as likely to be prescribed antidepressants, compared to the general population and high rates or prescribing are found in ethnic minority patients. 

People with Learning Disabilities may be more vulnerable to adverse effects of medicines and may have difficulty reporting them.

There are a number of well documented side effects of antipsychotics that we are concerned about in people with Learning Disabilities.

In order to build on the great work done via the STOMP and STAMP initiatives, Health Innovation Wessex has brough together a group of clinicians who work in this area. The action plan that Wessex Learning Disabilities Working Group has developed has been tested with people with lived experience of Learning Disabilities and together we are now working on delivering our plan.


We are supporting our integrated care systems to take a systems approach to change that brings together NHS providers, social care, voluntary sector and lived experience.

A key aim of our work is to improve the quality and quantity of Structured Medication Reviews carried out in people with Learning Disabilities. To access the resources to support this work, please access further information here: Structured Medication Reviews in adults with a Learning Disability | Programme toolkits

Antipsychotics in Learning Disabilities Masterclass - 4 June 2026

Click here for presentation from Antipsychotics in Learning Disabilities Masterclass - 4 June 2026.


Treatment to prevention icon

Useful links





Meet our Innovation adoption team

How can we help you?

If you’d like to get in touch please
email medicines.optimisation@hiwessex.net

More projects

See all projects

Case studies

See all case studies

Events

See all events

News

See all news

Videos & podcasts

See all videos & podcasts

Stay connected, sign up for
our monthly newsletter

Sign up now Funding newsletter